Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

ClinicalTrials.gov ID: NCT04166773

Public ClinicalTrials.gov record NCT04166773. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 8:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to see if the study drug, tirzepatide administered once weekly, is safe and effective as a treatment for Nonalcoholic Steatohepatitis (NASH).

Study identification

NCT ID
NCT04166773
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
190 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 19, 2019 (Actual)
Primary completion
Dec 11, 2023 (Actual)
Completion
Jan 10, 2024 (Actual)
Last update posted
Jan 24, 2025

2019 – 2024

United States locations

U.S. sites
47
U.S. states
17
U.S. cities
40
Facility City State ZIP Site status
University of Alabama-The Kirklin Clinic Birmingham Alabama 35205 —
Synexus Clinical Research US, Inc. Chandler Arizona 85224 —
Fresno Clinical Research Center Fresno California 93720 —
National Research Institute - Huntington Park Huntington Park California 90255 —
UCSD - Altman Clinical and Translational Research Institute (ACTRI) La Jolla California 92037 —
National Research Institute - Wilshire Los Angeles California 90057 —
Catalina Research Institute, LLC Montclair California 91763 —
Diabetes Medical Center of California Northridge California 91325 —
Velocity Clinical Research, Panorama City Panorama City California 91402 —
Inland Empire Clinical Trials, LLC Rialto California 92377 —
Velocity Clinical Research, Santa Ana Santa Ana California 92704 —
Excel Medical Clinical Trials Boca Raton Florida 33434 —
Alliance for Multispecialty Research, LLC Coral Gables Florida 33134 —
Research Centers of America ( Hollywood ) Hollywood Florida 33024 —
East Coast Institute for Research, LLC Jacksonville Florida 32204 —
IHS Health Research Kissimmee Florida 34741 —
Accel Research Sites - Maitland Clinical Research Unit Maitland Florida 32751 —
Clinical Pharmacology of Miami Miami Florida 33014 —
The Center for Digestive Health Orlando Florida 32803 —
Synexus Clinical Research US, Inc. Orlando Florida 32806 —
Synexus Clinical Research US, Inc. The Villages Florida 32162 —
Synexus Clinical Research Chicago Illinois 60602 —
Indiana University Health Hospital Indianapolis Indiana 46202 —
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265 —
Cotton O'Neil Clinical Research Center Topeka Kansas 66606 —
Alliance for Multispecialty Research, LLC Wichita Kansas 67207 —
Tandem Clinical Research Marrero Louisiana 70072 —
The National Diabetes & Obesity Research Institute Biloxi Mississippi 39532 —
Southern Therapy and Advanced Research (STAR) LLC Jackson Mississippi 39216 —
Buffalo Clinical and Translational Research Center Buffalo New York 14203 —
NYU Langone Health New York New York 10016 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
Montefiore Medical Center The Bronx New York 10467 —
Diabetes & Endocrinology Consultants, PC Morehead City North Carolina 28557 —
Geisinger Medical Center Danville Pennsylvania 17822 —
WR-Clinsearch, LLC Chattanooga Tennessee 37421 —
Dallas Diabetes Research Center Dallas Texas 75230 —
Radiant Research - Dallas North Dallas Texas 75231 —
Liver Center of Texas, PLLC Dallas Texas 75234-7858 —
Texoma Medical Center Denison Texas 75020 —
Texas Diabetes & Endocrinology, P.A. Round Rock Texas 78681 —
American Research Corporation at Texas Liver Institute San Antonio Texas 78215 —
Synexus Clinical Research US, Inc. San Antonio Texas 78229 —
Endeavor Clinical Trials San Antonio Texas 78240 —
National Clinical Research, Inc Richmond Virginia 23294 —
Virginia Commonwealth University (VCU) Medical Center Richmond Virginia 23298 —
Harborview Medical Center/University of Washington Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04166773, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 24, 2025 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04166773 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →